This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

June 14-16, 2022
Intercontinental Mark Hopkins HotelSan Francisco, California

June 14-16, 2022
Intercontinental Mark Hopkins Hotel,
San Francisco, California

CAR AND T CELL THERAPIES: IMPROVE THE SAFETY & EFFICACY OF YOUR NOVEL CAR MODALITIES THROUGH TRANSLATIONAL SCIENCE AND CUTTING EDGE CLINICAL DATA

Revolutionizing cell and gene engineering - ground breaking autologous and allogeneic treatments for blood borne and solid tumors

2022 Dates Announced!

Mark your calendar to join us at next year's event, scheduled for June 14-16, 2022 in San Francisco!  Sign up for email updates below for the latest news on our scientific agenda and early registration offers.

Novel Technological Advances & Applications to help you Revolutionize Early Phase Development

Below are the key topics covered at our 2021 event which was delivered last June in a 100% digital format.

Next Generation Solid Tumour Approaches

  • Understand novel combination approaches to improve efficacy in solid tumours
  • Get to grips with the identification of new targets for the treatment of broad patient populations
  • Hear the latest on engineering techniques to improve mechanism of action

Is the Future Allogeneic? CARNK, iPSc and Future Considerations

  • Benchmark with key companies discussing current trends and successes seen here
  • Join the debate around the future of CART and if allogeneic will replace autologous therapies
  • Have your say on the use of allogeneic treatments for solid and hematological malignancies

Novel CAR and T Cell Modalities – Safety, Efficacy and Clinical Data

  • Stay abreast of the latest clinical data for CAR-NK, CAR-Macrophage, Modified TILs and more…
  • Revolutionize how novel CARs and TCRs are being explored
  • Create a feedback loop between clinical trials and translational science for product improvement

CONNECT WITH KEY BUYERS AT NEXT GENERATION CAR & T CELL THERAPIES 2022 VIRTUALLY

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.  

Contact Perri Lucatello: PLucatello@informaconnectls.com | +44 (0)7717 508900